Sfoglia per Autore
Long-term follow-up of front-line treatment of hairy cell leukemia with 2-chlorodeoxyadenosine
2004 ZINZANI PL; TANI M; MARCHI E; STEFONI V; ALINARI L; MUSURACA G; GABRIELE A; PILERI S; BACCARANI M.
Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphoma.
2004 ZINZANI P.; PULSONI A; PERROTTI A; SOVERINI S; ZAJA F; DE RENZO A; STORTI S; LAUTA VM; GUARDIGNI L; GENTILINI P; TUCCI A; MOLINARI AL; GOBBI M; FALINI B; FATTORI PP; CICCONE F; ALINARI L; MARTELLI M; PILERI S; TURA S; BACCARANI M.
18F-FDG PET early after radiotherapy in lymphoma patients.
2004 CASTELLUCCI P; ZINZANI P; NANNI C; FARSAD M; MORETTI A; ALINARI L; BATTISTA G; PETTINATO C; MARENGO M; BOSCHI S; CANINI R; BACCARANI M.; MONETTI N; FANTI S.
Effectiveness of Fludarabine, Idarubicin and Cyclophosphade (FLUIC) Combination Regimen for Young Patients with Untreated Non-Follicular Low-Grade Non-Hodgkin’s Lymphoma.
2004 Zinzani P.L.; Pulsoni A.; Gentilini P.; Visani G.; Perrotti A.; Molinari A.L.; Guardigni L.; Tani M.; Valliva N.; Stefoni V.; Alinari L.; Martelli M.; Bonifazi F.; Pileri S.; Tura S.; Baccarani M.
Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma.
2004 ZINZANI P.; STEFONI V; MUSURACA G; TANI M; ALINARI L; GABRIELE A; MARCHI E; PILERI S; BACCARANI M.
High-dose therapy with autologous transplantation for aggressive non-Hodgkin's lymphoma: the Bologna experience
2004 ZINZANI P.L.; TANI M.; GABRIELE A.; GHERLINZONI F.; DE VIVO A.; RICCI P.; BANDINI G.; LEMOLI R.M.; MOTTA M.R.; RIZZI S.; GUIDICE V.; ZOMPATORI M.; STEFONI V.; ALINARI L.; MUSURACA G.; MARCHI E.; BASSI S.; CONTE R.; PILERI S.; TURA S.; BACCARANI M.
Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients.
2004 ZINZANI PL; FANTI S; BATTISTA G; TANI M; CASTELLUCCI P; STEFONI V; ALINARI L; FARSAD M; MUSURACA G; GABRIELE A; MARCHI E; NANNI C; CANINI R.; MONETTI N; BACCARANI M
Value of oxaliplatin treatment in heavily pretreated patients with non-Hodgkin's lymphoma.
2005 Alinari L; Musuraca G; Tani M; Stefoni V; Gabriele A; Marchi E; Fina M; De Vivo A; Pileri S; Baccarani M; Zinzani PL
Gemcitabine as frontline treatment for cutaneous T-cell lymphoma.
2005 Marchi E; Alinari L; Tani M; Stefoni V; Pimpinelli N; Berti E; Pagano L; Bernengo MG; Zaja F; Rupoli S; Pileri S; Baccarani M; Zinzani PL
Potential pitfalls of 18F-FDG PET in a large series of patients treated for malignant lymphoma: prevalence and scan interpretation.
2005 CASTELLUCCI P.; NANNI C.; FARSAD M.; ALINARI L.; ZINZANI P.; STEFONI V.; BATTISTA G.; VALENTINI D.; PETTINATO C.; MARENGO M.; BOSCHI S.; CANINI R.; BACCARANI M.; MONETTI N.; FRANCHI R.; RAMPIN L.; FANTI S.; RUBELLO D.
Phase II trial of temozolomide in patients with pretreated cutaneous T-cell lymphoma.
2005 Tani M; Fina M; Alinari L; Stefoni V; Baccarani M; Zinzani PL.
Identification of outcome predictors in diffuse large B-cell lymphoma. Immunohistochemical profiling of homogeneously treated de novo tumors with nodal presentation on tissue micro-arrays.
2005 ZINZANI P.; DIRNHOFER S; SABATTINI E; ALINARI L; PICCALUGA PP; STEFONI V; TANI M; MUSURACA G; MARCHI E; FALINI B; BACCARANI M; PILERI SA.
Role of anemia in survival of patients with elderly aggressive non-Hodgkin's lymphoma after chemotherapy.
2005 Zinzani PL; Tani M; Alinari L;Molinari AL;Stefoni V.;Visani G.; Gentilini P.; Guardigni L.; Fina M.; Baccarani M.
Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients.
2005 ISIDORI A; TANI M; BONIFAZI F; ZINZANI P; CURTI A; MOTTA MR; RIZZI S; GIUDICE V; FARESE O; ROVITO M; ALINARI L; CONTE R; BACCARANI M.; LEMOLI RM.
18 F-FDG PET in malignant lymphoma: significance of positive findings
2005 Castellucci P.; Zinzani P.L.; Nanni C.; Farsad M.; Moretti A.; Alinari L.; Battista G.; Tani M.; Stefoni V.; Canini R.; Monetti N.; Rubello D.; Alavi A.; Franchi R.; Fanti S.
Rituximab in primary conjunctiva lymphoma.
2005 ZINZANI P.; ALINARI L; STEFONI V; LOFFREDO A; PICHIERRI P; POLITO E.
Efficacy and safety of oral fludarabine/cyclophosphamide regimen in previously treated indolent lymphomas.
2005 Stefoni V; Alinari L; Musuraca G; Tani M; Marchi E; Gabriele A; Fina M; Pileri S; Baccarani M; Zinzani PL.
Preliminary observations of a phase II study of reduced-dose alemtuzumab treatment in patients with pretreated T-cell lymphoma.
2005 ZINZANI PL; ALINARI L; TANI M; FINA M; PILERI S; BACCARANI M.
Early positron emission tomography (PET) restaging: a predictive final response in Hodgkin's disease patients.
2006 Zinzani PL.; Tani M.; Fanti S.; Alinari L.; Musuraca G.; Marchi E.; Stefoni V.; Castellucci P.; Fina M.; Farshad M.; Pileri S.; Baccarani M.
18F-FDG PET in mucosa-associated lymphoid tissue (MALT) lymphoma.
2006 Alinari L; Castellucci P; Elstrom R; Ambrosini V; Stefoni V; Nanni C; Berkowitz A; Tani M; Farsad M; Franchi R; Fanti S; Zinzani PL.
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
---|---|---|---|---|---|---|
Long-term follow-up of front-line treatment of hairy cell leukemia with 2-chlorodeoxyadenosine | ZINZANI PL; TANI M; MARCHI E; STEFONI V; ALINARI L; MUSURACA G; GABRIELE A; PILERI S; BACCARANI M. | 2004-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphoma. | ZINZANI P.; PULSONI A; PERROTTI A; SOVERINI S; ZAJA F; DE RENZO A; STORTI S; LAUTA VM; GUARDIGNI ...L; GENTILINI P; TUCCI A; MOLINARI AL; GOBBI M; FALINI B; FATTORI PP; CICCONE F; ALINARI L; MARTELLI M; PILERI S; TURA S; BACCARANI M. | 2004-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
18F-FDG PET early after radiotherapy in lymphoma patients. | CASTELLUCCI P; ZINZANI P; NANNI C; FARSAD M; MORETTI A; ALINARI L; BATTISTA G; PETTINATO C; MAREN...GO M; BOSCHI S; CANINI R; BACCARANI M.; MONETTI N; FANTI S. | 2004-01-01 | CANCER BIOTHERAPY & RADIOPHARMACEUTICALS | - | 1.01 Articolo in rivista | - |
Effectiveness of Fludarabine, Idarubicin and Cyclophosphade (FLUIC) Combination Regimen for Young Patients with Untreated Non-Follicular Low-Grade Non-Hodgkin’s Lymphoma. | Zinzani P.L.; Pulsoni A.; Gentilini P.; Visani G.; Perrotti A.; Molinari A.L.; Guardigni L.; Tani... M.; Valliva N.; Stefoni V.; Alinari L.; Martelli M.; Bonifazi F.; Pileri S.; Tura S.; Baccarani M. | 2004-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma. | ZINZANI P.; STEFONI V; MUSURACA G; TANI M; ALINARI L; GABRIELE A; MARCHI E; PILERI S; BACCARANI M. | 2004-01-01 | CANCER | - | 1.01 Articolo in rivista | - |
High-dose therapy with autologous transplantation for aggressive non-Hodgkin's lymphoma: the Bologna experience | ZINZANI P.L.; TANI M.; GABRIELE A.; GHERLINZONI F.; DE VIVO A.; RICCI P.; BANDINI G.; LEMOLI R.M....; MOTTA M.R.; RIZZI S.; GUIDICE V.; ZOMPATORI M.; STEFONI V.; ALINARI L.; MUSURACA G.; MARCHI E.; BASSI S.; CONTE R.; PILERI S.; TURA S.; BACCARANI M. | 2004-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients. | ZINZANI PL; FANTI S; BATTISTA G; TANI M; CASTELLUCCI P; STEFONI V; ALINARI L; FARSAD M; MUSURACA ...G; GABRIELE A; MARCHI E; NANNI C; CANINI R.; MONETTI N; BACCARANI M | 2004-01-01 | BRITISH JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |
Value of oxaliplatin treatment in heavily pretreated patients with non-Hodgkin's lymphoma. | Alinari L; Musuraca G; Tani M; Stefoni V; Gabriele A; Marchi E; Fina M; De Vivo A; Pileri S; Bacc...arani M; Zinzani PL | 2005-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
Gemcitabine as frontline treatment for cutaneous T-cell lymphoma. |
Marchi E; Alinari L; Tani M; Stefoni V; Pimpinelli N; Berti E; Pagano L; Bernengo MG; Zaja F; Ru...poli S; Pileri S; Baccarani M; Zinzani PL |
2005-01-01 | CANCER | - | 1.01 Articolo in rivista | - |
Potential pitfalls of 18F-FDG PET in a large series of patients treated for malignant lymphoma: prevalence and scan interpretation. | CASTELLUCCI P.; NANNI C.; FARSAD M.; ALINARI L.; ZINZANI P.; STEFONI V.; BATTISTA G.; VALENTINI D....; PETTINATO C.; MARENGO M.; BOSCHI S.; CANINI R.; BACCARANI M.; MONETTI N.; FRANCHI R.; RAMPIN L.; FANTI S.; RUBELLO D. | 2005-01-01 | NUCLEAR MEDICINE COMMUNICATIONS | - | 1.01 Articolo in rivista | - |
Phase II trial of temozolomide in patients with pretreated cutaneous T-cell lymphoma. | Tani M; Fina M; Alinari L; Stefoni V; Baccarani M; Zinzani PL. | 2005-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
Identification of outcome predictors in diffuse large B-cell lymphoma. Immunohistochemical profiling of homogeneously treated de novo tumors with nodal presentation on tissue micro-arrays. | ZINZANI P.; DIRNHOFER S; SABATTINI E; ALINARI L; PICCALUGA PP; STEFONI V; TANI M; MUSURACA G; MAR...CHI E; FALINI B; BACCARANI M; PILERI SA. | 2005-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
Role of anemia in survival of patients with elderly aggressive non-Hodgkin's lymphoma after chemotherapy. | Zinzani PL; Tani M; Alinari L;Molinari AL;Stefoni V.;Visani G.; Gentilini P.; Guardigni L.; Fina ...M.; Baccarani M. | 2005-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients. | ISIDORI A; TANI M; BONIFAZI F; ZINZANI P; CURTI A; MOTTA MR; RIZZI S; GIUDICE V; FARESE O; ROVITO... M; ALINARI L; CONTE R; BACCARANI M.; LEMOLI RM. | 2005-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
18 F-FDG PET in malignant lymphoma: significance of positive findings | Castellucci P.; Zinzani P.L.; Nanni C.; Farsad M.; Moretti A.; Alinari L.; Battista G.; Tani M.; ...Stefoni V.; Canini R.; Monetti N.; Rubello D.; Alavi A.; Franchi R.; Fanti S. | 2005-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.01 Articolo in rivista | - |
Rituximab in primary conjunctiva lymphoma. | ZINZANI P.; ALINARI L; STEFONI V; LOFFREDO A; PICHIERRI P; POLITO E. | 2005-01-01 | LEUKEMIA RESEARCH | - | 1.01 Articolo in rivista | - |
Efficacy and safety of oral fludarabine/cyclophosphamide regimen in previously treated indolent lymphomas. |
Stefoni V; Alinari L; Musuraca G; Tani M; Marchi E; Gabriele A; Fina M; Pileri S; Baccarani M; Z...inzani PL. |
2005-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
Preliminary observations of a phase II study of reduced-dose alemtuzumab treatment in patients with pretreated T-cell lymphoma. | ZINZANI PL; ALINARI L; TANI M; FINA M; PILERI S; BACCARANI M. | 2005-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
Early positron emission tomography (PET) restaging: a predictive final response in Hodgkin's disease patients. | Zinzani PL.; Tani M.; Fanti S.; Alinari L.; Musuraca G.; Marchi E.; Stefoni V.; Castellucci P.; F...ina M.; Farshad M.; Pileri S.; Baccarani M. | 2006-01-01 | ANNALS OF ONCOLOGY | - | 1.01 Articolo in rivista | - |
18F-FDG PET in mucosa-associated lymphoid tissue (MALT) lymphoma. |
Alinari L; Castellucci P; Elstrom R; Ambrosini V; Stefoni V; Nanni C; Berkowitz A; Tani M; Farsa...d M; Franchi R; Fanti S; Zinzani PL. |
2006-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile